What does MPDP mean in DEVELOPMENT

MPDP stands for Medical Product Development Program. It is a collaborative effort between the US Food and Drug Administration (FDA) and private industry to enhance the development of safe and effective medical products.

The objectives of MPDP are to foster collaboration between stakeholders, make use of real-world evidence, streamline premarket approval processes, shorten regulatory review times, ensure product safety and efficacy, facilitate pilot projects in order to test novel approaches to medical product development, promote new technologies into practice more quickly, and improve patient access.

The program involves various stakeholders such as manufacturers, health care providers, patients, researchers, the FDA, and other members of the public health community.

The program provides a forum for exchanging ideas about research designs that can be used in regulated clinical trials or other experimental techniques that increase efficiency in product development or verification/validation activities. Additionally, it enables companies to explore innovative approaches such as accelerated approval pathways or obtaining regulatory approval without conducting traditional clinical trials based on observational data from real-world evidence sources.

Yes! There is a website dedicated to providing educational resources about the Medical Product Development Program including webinars on topics related to drug development as well as case studies demonstrating how different organizations have successfully applied these principles.